FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Veterinary ophthalmology2011; 15(3); 145-152; doi: 10.1111/j.1463-5224.2011.00951.x

Characterization of cytokines associated with Th17 cells in the eyes of horses with recurrent uveitis.

Abstract: Equine recurrent uveitis (ERU) is a spontaneous disease that is the most common cause of blindness in horses, affecting up to 15% of the horse population. Th17 cells are a major cell population driving the pathogenesis in several mouse models of autoimmune inflammation, including experimental autoimmune uveitis. The purpose of this study is to investigate the role a Th17 cell-mediated response plays in the pathogenesis of ERU. Methods: Banked, Davidson's-fixed equine globes histopathologically diagnosed with ERU (n = 7) were compared immunohistochemically with healthy control globes (n = 7). Immunohistochemical staining was performed using a pan-Leptospira antibody and antibodies against IL-6, IL-17, and IL-23. Additionally, immunostaining was performed for T-cell (CD3) and B-cell (CD79α) markers. Specificity of immunoreactivity was confirmed by western blot analysis. Results: Immunohistochemical staining was positive for IL-6, IL-17, and IL-23 within the cytoplasm of nonpigmented ciliary epithelial cells and mononuclear inflammatory cells infiltrating the iris, and ciliary body of ERU horses (n = 7) but negative in controls (n = 7). ERU-affected eyes were CD3 positive (n = 7) and CD79α negative (n = 7). Staining for Leptospira was negative in all ERU and control globes. Conclusions: Strong immunoreactivity for IL-6, IL-17, and IL-23, in conjunction with the fact that T lymphocytes are the predominating inflammatory cells present in ERU, suggests that IL-17-secreting helper T-cells play a role in the pathogenesis of ERU. These findings suggest that horses with ERU may serve as a naturally occurring animal model for autoimmune uveitis.
© 2011 American College of Veterinary Ophthalmologists.
Get Full Text
Publication Date: 2011-10-07 PubMed ID: 22051225DOI: 10.1111/j.1463-5224.2011.00951.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study explores the role of Th17 immune cells in equine recurrent uveitis (ERU), a disease causing blindness in horses. The findings suggest these cells and their associated cytokines may be involved in ERU’s development, suggesting potential for horses with ERU to function as models for studying autoimmune uveitis.

Objective and methods of the study

  • The research aims to understand the part Th17 cells, known to drive auto-immune inflammation in mouse models, play in recurring uveitis in horses.
  • The researchers used banked, Davidson’s-fixed equine globes diagnosed histopathologically to have ERU and compared them via immunohistochemical analysis with healthy globes.
  • Cytokines associated with Th17 cells such as IL-6, IL-17, and IL-23 were targeted for immunohistochemical staining, along with T-cell (CD3) and B-cell (CD79α) markers.
  • Immunoreactivity specificity was established using the western blot analysis method.

Results of the study

  • The nonpigmented ciliary epithelial cells and inflammatory mononuclear cells infiltrating the iris and ciliary body of ERU horses displayed positive staining for IL-6, IL-17, and IL-23, but the control group did not show this pattern.
  • ERU-affected eyes had T-cell (CD3) positivity and did not have B-cell (CD79α) activity.
  • All ERU and control globes had negative staining for Leptospira.

Conclusions and implications of the study

  • The researchers observed strong immunoreactivity for IL-6, IL-17, IL-23, which along with the predominance of T lymphocytes as the inflammatory cells in ERU, suggests the role of IL-17-secreting helper T-cells in the pathogenesis of ERU.
  • The findings suggest horses with ERU could serve as natural models for studying autoimmune uveitis, thus expanding potential research into this area of study.

Cite This Article

APA
Regan DP, Aarnio MC, Davis WS, Carmichael KP, Vandenplas ML, Lauderdale JD, Moore PA. (2011). Characterization of cytokines associated with Th17 cells in the eyes of horses with recurrent uveitis. Vet Ophthalmol, 15(3), 145-152. https://doi.org/10.1111/j.1463-5224.2011.00951.x

Publication

Veterinary ophthalmology
ISSN: 1463-5224
NlmUniqueID: 100887377
Country: England
Language: English
Volume: 15
Issue: 3
Pages: 145-152

Researcher Affiliations

Regan, Daniel P
  • Department of Small Animal Medicine and Surgery, The University of Georgia College of Veterinary Medicine, 501 D.W. Brooks Drive, Athens, GA 30602, USA.
Aarnio, Megan C
    Davis, Wesley S
      Carmichael, K Paige
        Vandenplas, Michel L
          Lauderdale, James D
            Moore, Phillip A

              MeSH Terms

              • Animals
              • Blotting, Western
              • Cytokines / genetics
              • Cytokines / metabolism
              • Eye / metabolism
              • Gene Expression Regulation / physiology
              • Horse Diseases / metabolism
              • Horses
              • Immunohistochemistry / veterinary
              • Paraffin Embedding
              • Th17 Cells / physiology
              • Uveitis / metabolism
              • Uveitis / veterinary

              Citations

              This article has been cited 17 times.
              1. Fleischer AB, Amann B, von Toerne C, Degroote RL, Schmalen A, Weißer T, Hauck SM, Deeg CA. Differential Expression of ARG1 and MRC2 in Retinal Müller Glial Cells During Autoimmune Uveitis. Biomolecules 2025 Feb 14;15(2).
                doi: 10.3390/biom15020288pubmed: 40001591google scholar: lookup
              2. Söth R, Hoffmann ALC, Deeg CA. Enhanced ROS Production and Mitochondrial Metabolic Shifts in CD4(+) T Cells of an Autoimmune Uveitis Model. Int J Mol Sci 2024 Oct 26;25(21).
                doi: 10.3390/ijms252111513pubmed: 39519064google scholar: lookup
              3. Degroote RL, Schmalen A, Hauck SM, Deeg CA. Unveiling Differential Responses of Granulocytes to Distinct Immunostimulants with Implications in Autoimmune Uveitis. Biomedicines 2023 Dec 20;12(1).
                doi: 10.3390/biomedicines12010019pubmed: 38275380google scholar: lookup
              4. Cassano JM, Leonard BC, Martins BC, Vapniarsky N, Morgan JT, Dow SW, Wotman KL, Pezzanite LM. Preliminary evaluation of safety and migration of immune activated mesenchymal stromal cells administered by subconjunctival injection for equine recurrent uveitis. Front Vet Sci 2023;10:1293199.
                doi: 10.3389/fvets.2023.1293199pubmed: 38162475google scholar: lookup
              5. Kucherenko MM, Sang P, Yao J, Gransar T, Dhital S, Grune J, Simmons S, Michalick L, Wulsten D, Thiele M, Shomroni O, Hennig F, Yeter R, Solowjowa N, Salinas G, Duda GN, Falk V, Vyavahare NR, Kuebler WM, Knosalla C. Elastin stabilization prevents impaired biomechanics in human pulmonary arteries and pulmonary hypertension in rats with left heart disease. Nat Commun 2023 Jul 21;14(1):4416.
                doi: 10.1038/s41467-023-39934-zpubmed: 37479718google scholar: lookup
              6. Plummer CE, Polk T, Sharma J, Bae SS, Barr O, Jones A, Kitchen H, Wilhelmy M, Devin K, Clay Smith W, Kolaczkowski BD, Larkin J 3rd. Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide. Sci Rep 2022 May 3;12(1):7177.
                doi: 10.1038/s41598-022-11338-xpubmed: 35505065google scholar: lookup
              7. Fingerhut L, Yücel L, Strutzberg-Minder K, von Köckritz-Blickwede M, Ohnesorge B, de Buhr N. Ex Vivo and In Vitro Analysis Identify a Detrimental Impact of Neutrophil Extracellular Traps on Eye Structures in Equine Recurrent Uveitis. Front Immunol 2022;13:830871.
                doi: 10.3389/fimmu.2022.830871pubmed: 35251020google scholar: lookup
              8. Cequier A, Sanz C, Rodellar C, Barrachina L. The Usefulness of Mesenchymal Stem Cells beyond the Musculoskeletal System in Horses. Animals (Basel) 2021 Mar 25;11(4).
                doi: 10.3390/ani11040931pubmed: 33805967google scholar: lookup
              9. Martin de Bustamante M, Gomez D, MacNicol J, Hamor R, Plummer C. The Fecal Bacterial Microbiota in Horses with Equine Recurrent Uveitis. Animals (Basel) 2021 Mar 9;11(3).
                doi: 10.3390/ani11030745pubmed: 33803123google scholar: lookup
              10. Degroote RL, Deeg CA. Immunological Insights in Equine Recurrent Uveitis. Front Immunol 2020;11:609855.
                doi: 10.3389/fimmu.2020.609855pubmed: 33488614google scholar: lookup
              11. MacDonald ES, Barrett JG. The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses. Front Vet Sci 2019;6:507.
                doi: 10.3389/fvets.2019.00507pubmed: 32039250google scholar: lookup
              12. Fingerhut L, Ohnesorge B, von Borstel M, Schumski A, Strutzberg-Minder K, Mörgelin M, Deeg CA, Haagsman HP, Beineke A, von Köckritz-Blickwede M, de Buhr N. Neutrophil Extracellular Traps in the Pathogenesis of Equine Recurrent Uveitis (ERU). Cells 2019 Nov 27;8(12).
                doi: 10.3390/cells8121528pubmed: 31783639google scholar: lookup
              13. Saldinger LK, Nelson SG, Bellone RR, Lassaline M, Mack M, Walker NJ, Borjesson DL. Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro. Vet Ophthalmol 2020 Jan;23(1):160-170.
                doi: 10.1111/vop.12704pubmed: 31441218google scholar: lookup
              14. Regan D, Garcia K, Thamm D. Clinical, Pathological, and Ethical Considerations for the Conduct of Clinical Trials in Dogs with Naturally Occurring Cancer: A Comparative Approach to Accelerate Translational Drug Development. ILAR J 2018 Dec 1;59(1):99-110.
                doi: 10.1093/ilar/ily019pubmed: 30668709google scholar: lookup
              15. Simeonova GP, Krastev SZ, Simeonov RS. Immunological and pathological investigations in equine experimental uveitis. Vet Res Commun 2016 Dec;40(3-4):107-115.
                doi: 10.1007/s11259-016-9659-4pubmed: 27344152google scholar: lookup
              16. Chernykh VV, Varvarinsky EV, Smirnov EV, Chernykh DV, Trunov AN. Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy. Indian J Ophthalmol 2015 Jan;63(1):33-6.
                doi: 10.4103/0301-4738.151464pubmed: 25686060google scholar: lookup
              17. Kulbrock M, Lehner S, Metzger J, Ohnesorge B, Distl O. A genome-wide association study identifies risk loci to equine recurrent uveitis in German warmblood horses. PLoS One 2013;8(8):e71619.
                doi: 10.1371/journal.pone.0071619pubmed: 23977091google scholar: lookup
              Subscribe to our newsletter
              Join 99,780 horse owners like you who receive our email updates on horse health and nutrition.